Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alignment Healthcare (ALHC) Change in Receivables (2020 - 2025)

Historic Change in Receivables for Alignment Healthcare (ALHC) over the last 6 years, with Q3 2025 value amounting to -$62.8 million.

  • Alignment Healthcare's Change in Receivables fell 4167.01% to -$62.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $81.5 million, marking a year-over-year increase of 14364.16%. This contributed to the annual value of $34.3 million for FY2024, which is 2719.11% up from last year.
  • Latest data reveals that Alignment Healthcare reported Change in Receivables of -$62.8 million as of Q3 2025, which was down 4167.01% from $69.1 million recorded in Q2 2025.
  • In the past 5 years, Alignment Healthcare's Change in Receivables ranged from a high of $69.1 million in Q2 2025 and a low of -$62.8 million during Q3 2025
  • For the 5-year period, Alignment Healthcare's Change in Receivables averaged around $9.5 million, with its median value being $14.2 million (2023).
  • Its Change in Receivables has fluctuated over the past 5 years, first crashed by 36772.62% in 2023, then surged by 27890.12% in 2025.
  • Alignment Healthcare's Change in Receivables (Quarter) stood at $10.9 million in 2021, then crashed by 58.29% to $4.5 million in 2022, then skyrocketed by 213.56% to $14.2 million in 2023, then rose by 5.81% to $15.1 million in 2024, then crashed by 517.27% to -$62.8 million in 2025.
  • Its Change in Receivables stands at -$62.8 million for Q3 2025, versus $69.1 million for Q2 2025 and $60.2 million for Q1 2025.